3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
3
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Sarcoma
1
Rare Tumour
1
Osteosarcoma
1
Carcinoma, Adenoid Cystic
1
Interventions
Gemcitabine
8
Cystectomy
6
Cisplatin
5
Mitomycin
3
toripalimab
2
tislelizumab
2
disitamab vedotin
2
Radiotherapy
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Drug Therapy
2
zimberelimab
1
trilaciclib
1
sacituzumab govitecan
1
nimotuzumab
1
entinostat
1
durvalumab
1
cemiplimab
1
Transurethral Resection of Bladder
1
Therapeutics
1
Synapsins
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
RC48 antibody
1
Olive Oil
1
Niacinamide
1
Niacin
1
Music Therapy
1
Liquid Biopsy
1
Immunonutrition Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Urinary Bladder Neoplasms
×
Epirubicin
×
Clear all
NCT06227065
2024-01-26
POLO
University of Bern
Phase 2
Not yet recruiting
28 enrolled